Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers
Clinical trial NCT02970539 · UNKNOWN
Trial details
- NCT number
- NCT02970539
- Sponsor
- Athenex, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-08
- Primary completion
- 2019-03-27
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.